Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6550
    +0.0027 (+0.42%)
     

  • OIL

    83.78
    +0.21 (+0.25%)
     

  • GOLD

    2,360.90
    +18.40 (+0.79%)
     

  • Bitcoin AUD

    98,221.03
    +815.17 (+0.84%)
     

  • CMC Crypto 200

    1,389.44
    -7.09 (-0.51%)
     

  • AUD/EUR

    0.6095
    +0.0022 (+0.36%)
     

  • AUD/NZD

    1.0983
    +0.0026 (+0.24%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,108.87
    +30.01 (+0.37%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,048.41
    +131.13 (+0.73%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Saving the World

TC Video

COVID-19 changed everything. It not only threatened our individual health and well being, but shook industries and economies across the globe. But the same could be said about the COVID-19 vaccines. Hear from BioNTech cofounder and CEO Ugur Sahin on the process of rapidly developing the world’s most sought after vaccine, alongside Pfizer, and the long-term potential of mRNA-based therapies. Sahin will be joined by Ursheet Parikh of Mayfield Fund to discuss what’s next for startups in this rapidly evolving industry.